rHIgM22 for Multiple Sclerosis
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Acorda Announces Phase 1 Results for Remyelinating Antibody in Multiple Sclerosis
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination | Semantic Scholar
Human IgMs promote neural growth A. A single dose of 500 μg of rHIgM22... | Download Scientific Diagram
Frontiers | Novel Molecular Leads for the Prevention of Damage and the Promotion of Repair in Neuroimmunological Disease
Pushing Forward: Remyelination as the New Frontier in CNS Diseases: Trends in Neurosciences
Dr. Brandon Beaber on Twitter: "A diagram looking at potential remyelinating therapies for MS from an excellent article in Elsevier. Authors: @Calabre04804429 @bannon_riley @marjangh20 https://t.co/vonWPAXOwH https://t.co/scbkmxyN4v" / Twitter
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis
PDF) Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia
Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia | Scientific Reports
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease | SpringerLink
Structure, Function, and Therapeutic Use of IgM Antibodies
Frontiers | Myelin Repair: From Animal Models to Humans
PDF) A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis
A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclero
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease | SpringerLink
rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination | Semantic Scholar
Stimulation of primary microglia with rHIgM22 promotes myelin... | Download Scientific Diagram
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination - ScienceDirect
Remyelination therapies: a new direction and challenge in multiple sclerosis | Nature Reviews Drug Discovery
